Pemoline in adult attention deficit hyperactivity disorder: Predictors of nonresponse

Journal of the American College Health Association

Volumn 45, Issue 5, 1997, Pages 225-229

  Heiligenstein, Eric ^a,b   Anders, Jeff ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Wisconsin University Health Services   (United States)

Author keywords

Attention deficit hyperactivity disorder; Pemoline; Psychostimulants

Indexed keywords

PEMOLINE;

ADULT; ARTICLE; DOSE RESPONSE; DRUG TOLERANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL BRAIN DYSFUNCTION; PATIENT COMPLIANCE; SYMPTOMATOLOGY; TREATMENT PLANNING;

EID: 0030897155     PISSN: 07448481     EISSN: None     Source Type: Journal    
DOI: 10.1080/07448481.1997.9936890     Document Type: Article

References (21)

1. Greenhill, L. L., 1992. Pharmacologic treatment of attention deficit hyperactivity disorder. Psychiatr Clin North Am, 15:1–27.
2. Barkley, R. A., 1990. Attention Deficit Hyperactivity Disorder:A Handbook for Diagnosis and Treatment, New York:Guilford.
3. Spencer, T., Biederman, J., Wilens, T., 1996. Phramaocotherapy of attention deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry, 35:409–432.
4. Abikoff, H., and Gittleman, R., 1985. The normalizing effects of methylphenidate on the classroom behavior of ADHD children. Abnorm Psychol, 13:33–44.
5. Barkely, R. A., 1977. A review of stimulant drug research with hyperactive children. J Child Psychol Psychiatry, 18:137–165.
6. Swanson, J. M., Granger, D., and Kliewer, W., 1987. Natural social behaviors in hyperactive children:Dose effects of methylphenidate. J Consult Clin Psychol, 55:187–193.
7. Wilens, T. E., and Biederman, J., 1992. The stimulants. Psychiatr Clin North Am, 15:191–222.
8. Klein, R. G., 1987. “ Pharmacotherapy of childhood hyperactivity:An update ”. In Psychopharmacology:The Third Generation of Progress, Edited by:Meltzer, H. Y., 1215–1225. New York:Raven.
9. Rappaport, M. D., Quinn, S. O., DuPaul, G. J., Quinn, E. P., and Kelly, K. L., 1989. Attention deficit disorder with hyperactivity and methylphenidate:The effects of dose and mastery level on children's learning performance. J Abnorm Child Psychol, 17:669–689.
10. Tannock, R., Schachar, R. J., Carr, R. P., and Logan, G. D., 1989. Dose-response effects on academic performance and overt behavior in hyperactive children. Pediatrics, 84:648–657.
11. Pelham, W. E., Greenslade, K. E., Vodde-Hamilton, M., 1990. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder:A comparison of standard methylphenidate, sustained-release methylphenidate, sustained release dextroamphetamine, and pemoline. Pediatrics, 86:226–237.
12. Safer, D. J., and Krager, J. M., 1994. The increased rate of stimulant treatment for hyperactive/inattentive students in secondary schools. Pediatrics, 4:462–464.
13. Pelham, W. E., Swamson, J. M., Furman, M. B., and Schwindt, H., 1995. Pemoline effects on children with ADHD:A time response by dose-response analysis on classroom measures. J Am Acad Child Adolesc Psychiatry, 34:1504–1513.
14. Heiligenstein, E., Johnston, H. F., and Nielsen, J. K., 1996. Retrospective study of pemoline therapy in college students with attention deficit hyperactivity disorder. J Am College Health, 45:35–40.
15. 1994. Diagnostic and Statistical Manual of Mental Disorders:DSM IV, Washington, DC:American Psychiatric Association.
16. Brown, T. E., and Gammon, G. D., Attention-Activation Disorders in High IQ Underachievers. Meeting Abstracts:American Academy of Child and Adolescent Psychiatry. Washington, DC
17. Guy, W., 1976. ECDEU Assessment Manual for Psychopharmacology, Rev ed., 217–222. National Institutes of Health, National Institute of Mental Health. Report DHEW-ADM 76–388
18. National Institute of Mental Health. 1985. Clinical global impressions. Psychopharmacol Bull, 21:839–43.
19. Elia, J., Borcherding, B. G., Rapoport, J. L., and Keysor, C., 1991. Methylphenidate and dextroamphetamine treatments of hyperactivity:Are there true nonresponders?. Psychiatric Research, 36:141–155.
20. Spencer, T., Wilens, T., Biederman, J., Faraone, S. V., Ablon, S., and Lapey, K., 1995. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry, 52:434–443.
21. Sallee, F. R., Stiller, R. L., and Perel, J. M., 1992. Pharmacodynamics of pemoline in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry, 31:224–251.